# Prebiotics in the Prevention of Necrotizing Enterocolitis

> **NCT00437567** · PHASE2 · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 260 (estimated)

## Conditions studied

- Necrotizing Enterocolitis

## Interventions

- **DIETARY_SUPPLEMENT:** Galacto-oligosaccharide (GOS)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00437567
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2014-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437567, "Prebiotics in the Prevention of Necrotizing Enterocolitis". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00437567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*